文献速递糖尿病

血管生成素样蛋白8在早期妊娠中改善妊娠期糖尿病的预测

Angiopoietin-like protein 8 in early pregnancy improves the prediction of gestational diabetes.
PubMed 文献 · Diabetologia · 2017-11-22

研究纳入474名妊娠12-16周孕妇,测量早期妊娠血管生成素样蛋白8(ANGPTL8)水平并于24-28周行75g口服葡萄糖耐量试验(OGTT)。发生妊娠期糖尿病(GDM)者早期ANGPTL8水平显著高于血糖正常者,且ANGPTL8最高四分位组GDM风险是最低四分位组的8.75倍;将ANGPTL8纳入传统预测模型可显著提高GDM预测的曲线下面积(AUC)。

要点

  • 早期妊娠ANGPTL8水平在后续发生GDM者中显著高于血糖正常者。
  • ANGPTL8最高四分位组GDM风险是最低四分位组的8.75倍(OR 8.75,95%CI 2.43, 31.58)。
  • ANGPTL8加入传统预测模型后GDM预测AUC由0.725升至0.772(p=0.019)。

核心结论

  • 研究提示早期妊娠ANGPTL8水平与24-28周妊娠期糖尿病风险显著且独立相关,联合传统危险因素可改善GDM预测。

研究设计与样本

  • 2015年8月至2016年1月招募474名妊娠约12-16周接受产前保健的孕妇,于首次产检时测量ANGPTL8水平,所有参与者在妊娠24-28周接受75g口服葡萄糖耐量试验(OGTT)。

主要发现

  • 发生GDM的孕妇早期妊娠ANGPTL8水平为2822 ± 938 pg/ml,血糖正常者为2120 ± 1118 pg/ml(p < 0.0001)。
  • 多变量逻辑回归显示ANGPTL8水平与GDM风险显著相关,且独立于传统危险因素。
  • ANGPTL8浓度最高四分位组较低四分位组GDM风险高8.75倍(OR 8.75,95%CI 2.43, 31.58)。
  • 将ANGPTL8纳入传统预测模型后,GDM预测的AUC由0.725提高至0.772(p = 0.019)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Screening high-risk individuals for gestational diabetes mellitus (GDM) in early pregnancy conventionally relies on established maternal risk factors; however, the sensitivity and specificity of these factors are not satisfactory. The present study aimed to determine whether the concentration of angiopoietin-like protein 8 (ANGPTL8), either alone or combined with other risk factors in early pregnancy, could be used to predict subsequent GDM. METHODS: From August 2015 to January 2016, 474 women receiving prenatal care at around 12-16 weeks of gestation were recruited into the study. ANGPTL8 levels were measured at the first prenatal visit. All the participants received a 75 g OGTT during weeks 24-28 of gestation. RESULTS: ANGPTL8 levels in early pregnancy were considerably higher in women who developed GDM than those who maintained normal glucose tolerance (2822 ± 938 vs 2120 ± 1118 pg/ml, respectively; p < 0.0001). Multivariable logistic regression revealed that ANGPTL8 levels were significantly associated with risk of GDM independent of conventional risk factors. In addition, women in the highest quartile of ANGPTL8 concentration had an 8.75-fold higher risk of developing GDM compared with women in the lowest quartile (OR8.75, 95%CI 2.43, 31.58). More importantly, incorporating ANGPTL8 into the conventional prediction model significantly increased the AUC for prediction of GDM (0.772vs 0.725; p = 0.019). CONCLUSIONS: Our study suggests that ANGPTL8 levels in early pregnancy are significantly and independently associated with risk of GDM at 24-28 weeks of gestation. Combining ANGPTL8 levels with conventional risk factors could thus improve the prediction of GDM.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Huang Y, Chen X, Chen X, et al. Angiopoietin-like protein 8 in early pregnancy improves the prediction of gestational diabetes. Diabetologia. 2017. PMID: 29167926. doi:10.1007/s00125-017-4505-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。